Rigor Reviewed

Rigor-Reviewed Manuscript

Prevention of type 2 diabetes through prediabetes remission without weight loss.

Name: Αlpha¹ Rigor Record — Prevention of type 2 diabetes through prediabetes remission without weight loss.
Item: Prevention of type 2 diabetes through prediabetes remission without weight loss.
Rating: 96
Author: Αlpha¹

Sandforth A, Arreola EV, Hanson RL, Wewer Albrechtsen NJ, Holst JJ, Ahrends R, Coman C, Gerst F, Lorza-Gil E, Cheng Y, Sandforth L, Katzenstein S, Ganslmeier M, Seissler J, Hauner H, Perakakis N, Wagner R, Machann J, Schick F, Peter A, Lehmann R, Weigert C, Maurer J, Preissl H, Heni M, Szendrödi J, Kopf S, Solimena M, Schwarz P, Blüher M, Häring HU, Hrabé de Angelis M, Schürmann A, Kabisch S, Mai K, Pfeiffer AFH, Bornstein S, Stumvoll M, Roden M, Stefan N, Fritsche A, Birkenfeld AL, Jumpertz von Schwartzenberg R

Paper source

Read full text (PMC)

Embed this Rigor badge

Αlpha¹ Rigor Review — 2.25★ (Weak), 0 critical, 4 high issues for “Prevention of type 2 diabetes through prediabetes remission without weight loss.”

Links back to this Rigor Record.

Αlpha¹ Editorial

This rigor review was examined and confirmed by Αlpha¹ Editorial · August 15, 2026

Αlpha¹ Rigor Review

Rigor Reviewed

2.25 / 5

Weak — serious problems found

Observational Study

Critical

High-priority

How this rating was calculated▸

Started at 5★ — deductions

IntegrityIntegrity concern ×3−1.5★
ClaimsEfficacy rests on an unvalidated surrogate endpoint−0.5★
CitationsUnresolved reference ×2−0.5★
ReportingStudy design partially met−0.25★

Model-reported confidence: highReviewer agreement: highEngine: 7.39.0Source: full text

Not verified in this report

The numeric-impossibility checks (GRIM/GRIMMER/DEBIT/SPRITE) did not run: 2 reported means were read, and their group size is not stated where the values are printed (this source has no machine-readable table structure). These checks need the count the mean was averaged over, so none was performed.

Problems surfaced6 types

Numerical inconsistencies1

Values that contradict each other or are impossible for the stated sample: recomputed p-values and test statistics, GRIM/GRIMMER checks on summary numbers, percentages against their own counts, totals against their parts, and estimates against their own confidence intervals.

Internal contradictions in the reported numbersAssessed

Overstated conclusions2

Conclusions that reach past what the paper's own results support — including a significance claim that no longer holds when the statistic is recomputed, and efficacy resting on an unvalidated surrogate endpoint.

Efficacy rests on an unvalidated surrogate endpointAssessed
Conclusions only partially backed by the presented evidenceAssessed

Data authenticity concerns1

An adversarial read for patterns associated with data that may not be genuine: results that look too clean, implausibly large effects, duplicated data or images, and methods that do not match the results reported.

Other integrity concernAssessed

Reporting gaps1

Required detail the manuscript never states — study design, biological variables, ethics approval and consent, key resources, statistical reporting, data and code availability, and overall transparency.

Study-design details incomplete (controls, blinding, power)Assessed

Broken references and links1

References checked against Crossref, OpenAlex and Retraction Watch for retractions and resolvability, plus declared data and code links probed for whether they resolve to content matching the paper.

References not resolvable to a published paperRecomputed

This Αlpha¹ Rigor Review uses AI Rigor Reviewers trained on a curated corpus of high-fidelity and retracted papers, with expert supervision and curation. It can still make mistakes; verify each finding against the source before relying on it.

The paper is a well-conducted post hoc analysis of a randomized trial with a validation cohort, reporting transparently on methods, ethics, and data availability. The main weakness is the lack of a priori powering and pre-specification for the subgroup analysis, which is acknowledged. Minor reporting issues include some threshold p-values and a few copyedit errors.

This is an observational post hoc analysis of a randomized trial; randomization and blinding are not applicable to the subgroup comparison. The statistics verification covered only 1 test (a subset of reported tests), so the absence of detected errors does not confirm overall statistical correctness. The citation check flagged 2 references not found in registries, which are addressed in the action items.

10 major claims checked against the paper's own evidence: 2 only partially supported (evidence backs part of the claim; gaps or caveats remain); the rest adequately supported.

Premise concern: surrogate not validated for clinical benefit.

Recomputed 1 test: 1 consistent, 0 inconsistent; 1 via agent-written checks.

3 integrity concerns flagged (0 high).

Reporting

Eight Dimensions7 pass · 1 warn

The introduction cites prior studies (DPPOS, PLIS, DIRECT) and identifies a gap: neither DIRECT nor DPP reported on preventive outcomes in patients who achieved remission without weight loss. The rationale is coherent, and the study aims to fill this gap. Limitations of prior work are implicitly addressed by focusing on a novel subgroup.

Sub-criteria

prior work citedADEQUATE

premise rationaleADEQUATE

limitations addressedADEQUATE

Per reviewer (2) — the votes behind the verdict

PASSReviewer 1· 90% conf

The paper establishes a clear scientific premise by citing prior work on prediabetes remission and weight loss, and logically links it to the study's objectives.

Evidence

paraphrase[Introduction, paragraph 2]

“The U.S. Diabetes Prevention Program (DPP) Outcome Study (DPPOS) has demonstrated that reversal of impaired glucose regulation to normal at least once during a lifestyle intervention (LI) was effective in reducing the risk of T2D and microvascular disease.”

direct quote[Introduction, paragraph 3]

“However, neither DIRECT nor DPP reported on the preventive outcomes of patients who did not reduce body weight but achieved remission.”